Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9

EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it will report its financial results for the first quarter ended March 31, 2018, after the market close, and will host a corporate update conference call and webcast on Wednesday, May 9, 2018, at 4:30 PM Eastern Time.

Conference Call DetailsWednesday, May 9th @ 4:30pm Eastern Time/1:30pm Pacific Time

About ZogenixZogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit www.zogenix.com.

CONTACT: Investors:Andrew McDonaldFounding Partner, LifeSci Advisors LLC646-597-6987[email protected]

You May Also Be Interested In

• Meta Platforms, IBM, Caterpillar fall premarket; American Airlines, Chipotle rise
• Lakeland Financial (LKFN) Tops Q1 EPS by 2c
• Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c